Periadjuvant pembrolizumab may improve outcomes over adjuvant pembrolizumab alone in patients with resectable stage III-IV melanoma, a phase 2 study suggests.
Researchers described possible associations between Kaposi sarcoma and Koebner phenomenon in a case series of patients with lesions appearing after a prior cutaneous injury.
Investigators in Spain developed an algorithm for diagnosing melanomas that had good diagnostic accuracy and was easier to perform than other diagnostic algorithms.
Researchers compared all-cause and melanoma-specific mortality in patients aged 15 to 39 years and 40 to 64 years with advanced melanoma.
Nonablative fractional laser-treated patients had lower rate of subsequent facial keratinocyte carcinoma development.